DMD and proximal spinal muscular atrophy: ,20 Use of another naturally occurring sequence, the DG9, a cell-penetrating peptide derived from human polyhomeotic 1 homolog (Hph-1) transcription factor, class of CPP, to improve delivery of PMOs against DMD and spinal muscular atrophy (SMA) targets, has been reported.21